Mitomycin induced hemolytic uremic syndrome;Mitomycininduziertes hämolytisch-urämisches syndrom

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 25-26, 2003, Pages 1399-1402

  Zeller, Geraldine ^a   Wandel, E ^a   Schwarting, A ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MITOMYCIN C;

ADULT; ANAMNESIS; ANURIA; ARTERY INTIMA PROLIFERATION; ARTICLE; BONE MARROW DEPRESSION; BRONCHOSCOPY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DRUG MEGADOSE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTENSIVE CARE; INTESTINE CARCINOMA; KIDNEY BIOPSY; KIDNEY FAILURE; LUNG EDEMA; LUNG HEMORRHAGE; RESPIRATORY FAILURE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; WEIGHT REDUCTION;

ANTIBIOTICS, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; HEMOLYTIC-UREMIC SYNDROME; HEMORRHAGE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MITOMYCIN; PROGNOSIS; SIGMOID NEOPLASMS;

EID: 0038348176     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40105     Document Type: Article

References (22)

1. Brailey LL, Brecher ME, Bandarenko N. Apheresis and the thrombotic thrombocytopenic purpura syndrome: current advances in diagnosis, pathophysiology and management. Therapeutic Apheresis 1999; 3: 20-24
2. Bosch T, Wendler T. Extracorporal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review. Therapeutic apheresis 2001; 5: 182-185
3. Cleary TG. Cytotoxin producing Escherichia coli and the hemolytic uremic syndrome. Pediatr Clin North Am 1988; 35: 485-501
4. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
5. Deschenes G, Casenave C, Grimont F et al. Cluster of cases of hemolytic uremic syndrome due to unpasteurised cheese. Pediatr Nephrol 1996; 10: 203-205
6. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Scharrer I. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic prurpura and the hemolytic uremic syndrome. Engl J Med 1998; 339: 1578-1584
7. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997; 89: 3097-3103
8. Hanna W, Crauss S, Regestor R, Murphey W. Renal disease after mitomycin C therapie. Cancer 1981; 48: 2583-2588
9. Kaplan A. Therapeutic apheresis for cancer related haemolytic uremic syndrome. Therapeutic apheresis 2000; 4: 201-206
10. Lohrmann HP, Adam W, Heymer B, Kubanek B. Microangiopathic haemolytic anemia in metastatic carcinoma: Report of eight cases. Ann Intern Med 1973; 79: 368-375
11. Medina PJ, Sipols JM, George JN. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 2001; 5: 286-293
12. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 8: 589-600
13. Moake JL, Byrnes JJ. Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematology/Oncology Clinics of North America 1996; 10: 485-497
14. Neahring B, Scott P, Visentin G et al. Anti-endothelial cell (EC) antibodies in plasma of patients with quinine-induced hemolytic uremic syndrome (HUS). Blood 1992; 80: 53a
15. Perez N, Spizziri F, Rahman R, Suarez A, Larrubia C, Lasarte P. Steroids in the haemolytic uremic syndrome. Pediatr Nephrol 1998; 12: 101-104
16. Raife T, Montgomery R. New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and haemolytic uremic syndrome. Review. Clin & Experim Hematology 2001; 5: 236-261
17. Rizzoni G, Claris-Appiani A, Edefonti et al. Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial. J Pediatr 1988; 112: 284-290
18. Röthele E, Krumme B, Rump C. Design of the prospective randomized study for the treatment of patients with thrombotic microangiopathy. Therapeutic apheresis 2000; 4: 327-331
19. Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Kidney international 2001; 60: 831
20. Sheldon R, Slaugther D. A syndrome of microangiopathic haemolytic anemia, renal impairment and pulmonary edema in chemotherapie-treated patients with adenocarcinoma. Cancer 1986; 58: 1428-1436
21. Torra R, Poch E, Torras A, Bombi JA, Revert L. Pulmonary hemorrhage as a clinical manifestation of haemolytic-uremic syndrome associated with mitomycin C therapie. Chemotherapie 1993; 39: 453-456
22. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 2000; 132: 794-799